The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Abstract
PURPOSE: To revise the staging system for cutaneous melanoma under the auspices of the American Joint Committee on Cancer (AJCC). MATERIALS AND METHODS: The prognostic factors analysis described in the companion publication (this issue), as well as evidence from the published literature, was used to assemble the tumor-node-metastasis criteria and stage grouping for the melanoma staging system. RESULTS: Major changes include (1) melanoma thickness and ulceration but not level of invasion to be used in the T category (except for T1 melanomas); (2) the number of metastatic lymph nodes rather than their gross dimensions and the delineation of clinically occult (ie, microscopic) versus clinically apparent (ie, macroscopic) nodal metastases to be used in the N category; (3) the site of distant metastases and the presence of elevated serum lactic dehydrogenase to be used in the M category; (4) an upstaging of all patients with stage I, II, and III disease when a primary melanoma is ulcerated; (5) a merging of satellite metastases around a primary melanoma and in-transit metastases into a single staging entity that is grouped into stage III disease; and (6) a new convention for defining clinical and pathologic staging so as to take into account the staging information gained from intraoperative lymphatic mapping and sentinel node biopsy. CONCLUSION: This revision will become official with publication of the sixth edition of the AJCC Cancer Staging Manual in the year 2002.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma
Morton, D. L. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420040034005 · Cited by 4,371
Self-citationThickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma
Breslow, A. (1970) · Annals of Surgery · doi:10.1097/00000658-197011000-00017 · Cited by 2,426
Balch, C. M., Soong, S.-J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,388
Self-citationThe histogenesis and biologic behavior of primary human malignant melanomas of the skin.
Clark, W. H., From, L., Bernardino, E. A., & Mihm, M. C. (1969) · PubMed · Cited by 2,112
Self-citationGershenwald, J. E., Thompson, W., Mansfield, P. F., Lee, J. E., Colome, M. I., Tseng, C.-H., Lee, J. J., Balch, C. M., Reintgen, D. S., & Ross, M. I. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.976 · Cited by 1,139
Self-citationBALCH, C. M., MURAD, T. M., SOONG, S.-J., INGALLS, A. L., HALPERN, N. B., & MADDOX, W. A. (1978) · Annals of Surgery · doi:10.1097/00000658-197812000-00004 · Cited by 576
Self-citationPrognostic factors in 1,521 melanoma patients with distant metastases.
Barth, A., Wanek, L. A., & Morton, D. L. (1995) · PubMed · Cited by 569
Self-citationBalch, C. M., Urist, M. M., Karakousis, C. P., Smith, T. J., Temple, W. J., Drzewiecki, K., Jewell, W. R., Bartolucci, A. A., Mihm, M. C., Barnhill, R., et al. (1993) · Annals of Surgery · doi:10.1097/00000658-199309000-00005 · Cited by 525
Self-citationThe prognostic significance of ulceration of cutaneous melanoma
Balch, C. M., Wilkerson, J. A., Murad, T. M., Soong, S.-J., Ingalls, A. L., & Maddox, W. A. (1980) · Cancer · doi:10.1002/1097-0142(19800615)45:12<3012::aid-cncr2820451223>3.0.co;2-o · Cited by 361
Self-citationBalch, C. M., Soong, S., Milton, G. W., Shaw, H. M., McGovern, V. J., Murad, T. M., McCarthy, W. H., & Maddox, W. A. (1982) · Annals of Surgery · doi:10.1097/00000658-198212001-00011 · Cited by 348
Self-citation
Cited by
Final Version of 2009 AJCC Melanoma Staging and Classification
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Atkins, M. B., Byrd, D. R., Buzaid, A. C., Cochran, A. J., Coit, D. G., Ding, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4799 · Cited by 4,602
Self-citationBalch, C. M., Soong, S.-J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,388
Self-citationGershenwald, J. E., Scolyer, R. A., Hess, K. R., Sondak, V. K., Long, G. V., Ross, M. I., Lazar, A. J., Faries, M. B., Kirkwood, J. M., McArthur, G. A., et al. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21409 · Cited by 2,283
Self-citationSentinel-Node Biopsy or Nodal Observation in Melanoma
Morton, D. L., Thompson, J. F., Cochran, A. J., Mozzillo, N., Elashoff, R., Essner, R., Nieweg, O. E., Roses, D. F., Hoekstra, H. J., Karakousis, C. P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060992 · Cited by 1,824
Self-citationAutomated Melanoma Recognition in Dermoscopy Images via Very Deep Residual Networks
Yu, L., Chen, H., Dou, Q., Qin, J., & Heng, P.-A. (2017) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2016.2642839 · Cited by 1,140
Vestergaard, M. E., Macaskill, P., Holt, P. E., & Menzies, S. W. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08713.x · Cited by 862
Azimi, F., Scolyer, R. A., Rumcheva, P., Moncrieff, M., Murali, R., McCarthy, S. W., Saw, R. P., & Thompson, J. F. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8539 · Cited by 856
Self-citationManagement of Cutaneous Melanoma
Tsao, H., Atkins, M. B., & Sober, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041245 · Cited by 855
Self-citationApoptosis and melanoma chemoresistance
Soengas, M. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206454 · Cited by 826
de Vries, I. J. M., Lesterhuis, W. J., Barentsz, J. O., Verdijk, P., van Krieken, J. H., Boerman, O. C., Oyen, W. J. G., Bonenkamp, J. J., Boezeman, J. B., Adema, G. J., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1154 · Cited by 821
Increasing Burden of Melanoma in the United States
Linos, E., Swetter, S. M., Cockburn, M. G., Colditz, G. A., & Clarke, C. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.423 · Cited by 746
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dummer, R., Hauschild, A., Guggenheim, M., Keilholz, U., & Pentheroudakis, G. (2012) · Annals of Oncology · doi:10.1093/annonc/mds229 · Cited by 714
Leiter, U., Stadler, R., Mauch, C., Hohenberger, W., Brockmeyer, N., Berking, C., Sunderkötter, C., Kaatz, M., Schulte, K.-W., Lehmann, P., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00141-8 · Cited by 707
Korn, E. L., Liu, P.-Y., Lee, S. J., Chapman, J.-A. W., Niedzwiecki, D., Suman, V. J., Moon, J., Sondak, V. K., Atkins, M. B., Eisenhauer, E. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7837 · Cited by 705
Self-citationNRAS mutation status is an independent prognostic factor in metastatic melanoma
Jakob, J. A., Bassett, R. L., Ng, C. S., Curry, J. L., Joseph, R. W., Alvarado, G. C., Rohlfs, M. L., Richard, J., Gershenwald, J. E., Kim, K. B., et al. (2012) · Cancer · doi:10.1002/cncr.26724 · Cited by 689
Self-citationGuo, J., Si, L., Kong, Y., Flaherty, K. T., Xu, X., Zhu, Y., Corless, C. L., Li, L., Li, H., Sheng, X., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.9275 · Cited by 688
Viguier, M., Lemaître, F., Verola, O., Cho, M.-S., Gorochov, G., Dubertret, L., Bachelez, H., Kourilsky, P., & Ferradini, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1444 · Cited by 686
Hino, R., Kabashima, K., Kato, Y., Yagi, H., Nakamura, M., Honjo, T., Okazaki, T., & Tokura, Y. (2010) · Cancer · doi:10.1002/cncr.24899 · Cited by 667
Melanoma epidemiology and trends
Garbe, C., & Leiter, U. (2009) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2008.09.001 · Cited by 657
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Michielin, O., van Akkooi, A. C. J., Ascierto, P. A., Dummer, R., & Keilholz, U. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz411 · Cited by 617
Acral Lentiginous Melanoma: Incidence and Survival Patterns in the United States, 1986-2005
Bradford, P. T., Goldstein, A. M., McMaster, M. L., & Tucker, M. A. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2008.609 · Cited by 599
Hoek, K. S., Schlegel, N. C., Brafford, P., Sucker, A., Ugurel, S., Kumar, R., Weber, B. L., Nathanson, K. L., Phillips, D. J., Herlyn, M., et al. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00322.x · Cited by 555
Kirkwood, J. M., Manola, J., Ibrahim, J., Sondak, V., Ernstoff, M. S., & Rao, U. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1103-3 · Cited by 552
Self-citationHauschild, A., Agarwala, S. S., Trefzer, U., Hogg, D., Robert, C., Hersey, P., Eggermont, A., Grabbe, S., Gonzalez, R., Gille, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.7636 · Cited by 548
Self-citationRiker, A. I., Enkemann, S. A., Fodstad, O., Liu, S., Ren, S., Morris, C., Xi, Y., Howell, P., Metge, B., Samant, R. S., et al. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-13 · Cited by 524
Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions
Talantov, D., Mazumder, A., Yu, J. X., Briggs, T., Jiang, Y., Backus, J., Atkins, D., & Wang, Y. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0683 · Cited by 521
Dadras, S. S., Paul, T., Bertoncini, J., Brown, L. F., Muzikansky, A., Jackson, D. G., Ellwanger, U., Garbe, C., Mihm, M. C., & Detmar, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64328-3 · Cited by 484
Self-citationGene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome
Winnepenninckx, V., Lazar, V., Michiels, S., Dessen, P., Stas, M., Alonso, S. R., Avril, M.-F., Ortiz Romero, P. L., Robert, T., Balacescu, O., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj103 · Cited by 480
The gene expression signatures of melanoma progression
Haqq, C., Nosrati, M., Sudilovsky, D., Crothers, J., Khodabakhsh, D., Pulliam, B. L., Federman, S., Miller, J. R., Allen, R. E., Singer, M. I., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501564102 · Cited by 433
A Comparative Review of Melanocytic Neoplasms
Smith, S. H., Goldschmidt, M. H., & McManus, P. M. (2002) · Veterinary Pathology · doi:10.1354/vp.39-6-651 · Cited by 431
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Ding, S., Byrd, D. R., Cascinelli, N., Cochran, A. J., Coit, D. G., Eggermont, A. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1627 · Cited by 410
Self-citationFocus on the Contribution of Oxidative Stress in Skin Aging
Papaccio, F., D′Arino, A., Caputo, S., & Bellei, B. (2022) · Antioxidants · doi:10.3390/antiox11061121 · Cited by 396
An Evidence-based Staging System for Cutaneous Melanoma
Balch, C. M., Soong, S.-J., Atkins, M. B., Buzaid, A. C., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A., Kirkwood, J. M., et al. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.3.131 · Cited by 391
Self-citationDilda, P. J., & Hogg, P. J. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.05.001 · Cited by 389
Chi, Z., Li, S., Sheng, X., Si, L., Cui, C., Han, M., & Guo, J. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-85 · Cited by 386
Cummins, D. L., Cummins, J. M., Pantle, H., Silverman, M. A., Leonard, A. L., & Chanmugam, A. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.4.500 · Cited by 367
Thompson, J. F., Soong, S.-J., Balch, C. M., Gershenwald, J. E., Ding, S., Coit, D. G., Flaherty, K. T., Gimotty, P. A., Johnson, T., Johnson, M. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.5812 · Cited by 363
Self-citationAgarwala, S. S., Kirkwood, J. M., Gore, M., Dreno, B., Thatcher, N., Czarnetski, B., Atkins, M., Buzaid, A., Skarlos, D., & Rankin, E. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.044 · Cited by 360
Self-citationTel, J., Aarntzen, E. H. J. G., Baba, T., Schreibelt, G., Schulte, B. M., Benitez-Ribas, D., Boerman, O. C., Croockewit, S., Oyen, W. J. G., van Rossum, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2583 · Cited by 353
Thrane, K., Eriksson, H., Maaskola, J., Hansson, J., & Lundeberg, J. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0747 · Cited by 337
Schmidt, H., Bastholt, L., Geertsen, P., Christensen, I. J., Larsen, S., Gehl, J., & von der Maase, H. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602702 · Cited by 329
Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes
Dadras, S. S., Lange-Asschenfeldt, B., Velasco, P., Nguyen, L., Vora, A., Muzikansky, A., Jahnke, K., Hauschild, A., Hirakawa, S., Mihm, M. C., et al. (2005) · Modern Pathology · doi:10.1038/modpathol.3800410 · Cited by 326
Self-citationDai, D. L., Martinka, M., & Li, G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.168 · Cited by 318
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline
Garbe, C., Peris, K., Hauschild, A., Saiag, P., Middleton, M., Spatz, A., Grob, J.-J., Malvehy, J., Newton-Bishop, J., Stratigos, A., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.032 · Cited by 317
Update on Bispectral Index monitoring
Johansen, J. W. (2006) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2005.08.004 · Cited by 313
Joseph, R. W., Elassaiss-Schaap, J., Kefford, R., Hwu, W.-J., Wolchok, J. D., Joshua, A. M., Ribas, A., Hodi, F. S., Hamid, O., Robert, C., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2386 · Cited by 310
Metastatic pathways and time courses in the orderly progression of cutaneous melanoma
Meier, F., Will, S., Ellwanger, U., Schlagenhauff, B., Schittek, B., Rassner, G., & Garbe, C. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04867.x · Cited by 305
Paulson, K. G., Iyer, J. G., Tegeder, A. R., Thibodeau, R., Schelter, J., Koba, S., Schrama, D., Simonson, W. T., Lemos, B. D., Byrd, D. R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.6308 · Cited by 302
Newton-Bishop, J. A., Beswick, S., Randerson-Moor, J., Chang, Y.-M., Affleck, P., Elliott, F., Chan, M., Leake, S., Karpavicius, B., Haynes, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1135 · Cited by 295
Thompson, J. F., Scolyer, R. A., & Kefford, R. F. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17951-3 · Cited by 292
Self-citationLadányi, A., Kiss, J., Somlai, B., Gilde, K., Fejős, Z., Mohos, A., Gaudi, I., & Tímár, J. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-007-0286-3 · Cited by 287
Ives, N. J., Stowe, R. L., Lorigan, P., & Wheatley, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0253 · Cited by 284
Di Giacomo, A. M., Ascierto, P. A., Pilla, L., Santinami, M., Ferrucci, P. F., Giannarelli, D., Marasco, A., Rivoltini, L., Simeone, E., Nicoletti, S. V., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70324-8 · Cited by 284
Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma
Scala, S., Ottaiano, A., Ascierto, P. A., Cavalli, M., Simeone, E., Giuliano, P., Napolitano, M., Franco, R., Botti, G., & Castello, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1887 · Cited by 280
Tacken, P. J., de Vries, I. J. M., Gijzen, K., Joosten, B., Wu, D., Rother, R. P., Faas, S. J., Punt, C. J. A., Torensma, R., Adema, G. J., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0318 · Cited by 272
Meier, F. (2005) · Frontiers in Bioscience · doi:10.2741/1755 · Cited by 267
Gender Differences in Melanoma Survival: Female Patients Have a Decreased Risk of Metastasis
Joosse, A., de Vries, E., Eckel, R., Nijsten, T., Eggermont, A. M. M., Hölzel, D., Coebergh, J. W. W., & Engel, J. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.354 · Cited by 266
The natural course of cutaneous melanoma
Leiter, U., Meier, F., Schittek, B., & Garbe, C. (2004) · Journal of Surgical Oncology · doi:10.1002/jso.20079 · Cited by 265
Lachiewicz, A. M., Berwick, M., Wiggins, C. L., & Thomas, N. E. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.4.515 · Cited by 264
Pellacani, G., Cesinaro, A. M., & Seidenari, S. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.08.022 · Cited by 263
Wei, L., Ding, K., & Hu, H. (2020) · IEEE Access · doi:10.1109/access.2020.2997710 · Cited by 262
Weide, B., Martens, A., Zelba, H., Stutz, C., Derhovanessian, E., Di Giacomo, A. M., Maio, M., Sucker, A., Schilling, B., Schadendorf, D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2508 · Cited by 261
Romero, L. M., & Remage-Healey, L. (2000) · General and Comparative Endocrinology · doi:10.1006/gcen.2000.7491 · Cited by 259
Romano, E., Scordo, M., Dusza, S. W., Coit, D. G., & Chapman, P. B. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.2063 · Cited by 256
Self-citationAscierto, P. A., Scala, S., Castello, G., Daponte, A., Simeone, E., Ottaiano, A., Beneduce, G., De Rosa, V., Izzo, F., Melucci, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0933 · Cited by 238
Zell, J. A., Cinar, P., Mobasher, M., Ziogas, A., Meyskens, F. L., & Anton-Culver, H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3604 · Cited by 176
Gomez Rossi, J., Rojas-Perilla, N., Krois, J., & Schwendicke, F. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.0269 · Cited by 141
Köhler, C., Nittner, D., Rambow, F., Radaelli, E., Stanchi, F., Vandamme, N., Baggiolini, A., Sommer, L., Berx, G., van den Oord, J. J., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.08.003 · Cited by 126
Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists.
Chen, S. C., Pennie, M. L., Kolm, P., Warshaw, E. M., Weisberg, E. L., Brown, K. M., Ming, M. E., & Weintraub, W. S. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00462.x · Cited by 122
Laverty, H. G., Wakefield, L. M., Occleston, N. L., O’Kane, S., & Ferguson, M. W. J. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.07.002 · Cited by 110
Pennie, M. L., Soon, S. L., Risser, J. B., Veledar, E., Culler, S. D., & Chen, S. C. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.4.488 · Cited by 93
Ugurel, S., Schrama, D., Keller, G., Schadendorf, D., Bröcker, E.-B., Houben, R., Zapatka, M., Fink, W., Kaufman, H. L., & Becker, J. C. (2008) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-007-0407-z · Cited by 88
“The pathological classiWcation of the primary (pT) was used to combine the parameters depth of invasion and ulceration, the classiWcation of distant metastasis (M) was used to combine the parameters distant metastasis localization and serum LDH, both according to AJCC 2001 staging criteria [16].”
MethodGeller, A. C., Elwood, M., Swetter, S. M., Brooks, D. R., Aitken, J., Youl, P. H., Demierre, M., & Baade, P. D. (2009) · Cancer · doi:10.1002/cncr.24162 · Cited by 91
“Melanoma survival is strongly associated with thickness of the primary lesion.(1) The median tumor thickness of cutaneous melanoma has decreased significantly over the past 3 decades as a result of earlier detection that has coincided with sharply rising incidence, particularly of thin melanoma, in Europe, Australia,…”
BackgroundChapman, P. B., Wu, D., Ragupathi, G., Lu, S., Williams, L., Hwu, W.-J., Johnson, D., & Livingston, P. O. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0345 · Cited by 70
Ricotti, C., Bouzari, N., Agadi, A., & Cockerell, C. J. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.08.011 · Cited by 63
Association of Microvessel Density with Infiltrating Cells in Human Cutaneous Malignant Melanoma
Kiss, J., Tímár, J., Somlai, B., Gilde, K., Fejős, Z., Gaudi, I., & Ladányi, A. (2007) · Pathology & Oncology Research · doi:10.1007/bf02893437 · Cited by 34
Smith, J. D., & George, C. (2012) · Journal of Personality Assessment · doi:10.1080/00223891.2012.656860 · Cited by 31
Hamama-Raz, Y., & Solomon, Z. (2006) · Journal of Individual Differences · doi:10.1027/1614-0001.27.3.172 · Cited by 30
Grange, F., Barbe, C., Aubin, F., Lipsker, D., Granel-Brocard, F., Velten, M., Dalac, S., Truchetet, F., Michel, C., Mitschler, A., et al. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2012.2937 · Cited by 29
Djerf Severinsson, E. A., Trinks, C., Gréen, H., Abdiu, A., Hallbeck, A.-L., Stål, O., & Walz, T. M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.118 · Cited by 24
Metadata
- Authors
- Balch, C. M., Buzaid, A. C., Soong, S.-J., Atkins, M. B., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A., Kirkwood, J. M., McMasters, K. M., Mihm, M. F., Morton, D. L., Reintgen, D. S., Ross, M. I., Sober, A., Thompson, J. A., & Thompson, J. F.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-08-15
- Volume
- 19
- Issue
- 16
- Pages
- 3635-3648
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2131365547
- Cited by
- 2,636
- References
- 25
- FWCI
- 56.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.